» Articles » PMID: 21554079

Integrating Structure-based and Ligand-based Approaches for Computational Drug Design

Overview
Journal Future Med Chem
Specialties Chemistry
Pharmacy
Date 2011 May 11
PMID 21554079
Citations 39
Authors
Affiliations
Soon will be listed here.
Abstract

Methods utilized in computer-aided drug design can be classified into two major categories: structure based and ligand based, using information on the structure of the protein or on the biological and physicochemical properties of bound ligands, respectively. In recent years there has been a trend towards integrating these two methods in order to enhance the reliability and efficiency of computer-aided drug-design approaches by combining information from both the ligand and the protein. This trend resulted in a variety of methods that include: pseudoreceptor methods, pharmacophore methods, fingerprint methods and approaches integrating docking with similarity-based methods. In this article, we will describe the concepts behind each method and selected applications.

Citing Articles

Prediction of SafD adhesin strong binding peptides for pilus proteins assembly suppression in the prevention of -induced biofilm formation using virtual mutagenesis studies.

Samanta P, Ghorai S In Silico Pharmacol. 2025; 13(1):25.

PMID: 39944120 PMC: 11811331. DOI: 10.1007/s40203-025-00313-9.


Virtual screening: hope, hype, and the fine line in between.

Nada H, Meanwell N, Gabr M Expert Opin Drug Discov. 2025; 20(2):145-162.

PMID: 39862145 PMC: 11844436. DOI: 10.1080/17460441.2025.2458666.


Bridging Structure- and Ligand-Based Virtual Screening through Fragmented Interaction Fingerprint.

Syahdi R, Jasial S, Maeda I, Miyao T ACS Omega. 2024; 9(37):38957-38969.

PMID: 39310180 PMC: 11411525. DOI: 10.1021/acsomega.4c05433.


Role of HSP90 in Type 2 Diabetes Mellitus and Its Association with Liver Diseases.

Nithyasree V, Magdalene P, Praveen Kumar P, Preethi J, Gromiha M Mol Biotechnol. 2024; .

PMID: 39162909 DOI: 10.1007/s12033-024-01251-1.


Structure-Activity Relationship Studies on VEGFR2 Tyrosine Kinase Inhibitors for Identification of Potential Natural Anticancer Compounds.

Verma M, Sarfraz A, Hasan I, Vasudev P, Khan F Med Chem. 2024; 20(6):646-661.

PMID: 38299297 DOI: 10.2174/0115734064247526231129080415.